,date,title,url
0,2000-03-31,天鹅股份年报,/disclosure/listedinfo/announcement/c/600829_1999_0.pdf
1,2000-08-05,天鹅股份半年报,/disclosure/listedinfo/announcement/c/600829_2000_1.pdf
2,2001-04-10,天鹅股份年报,/disclosure/listedinfo/announcement/c/600829_2000_0.pdf
3,2001-04-13,天鹅股份年报补充公告,/disclosure/listedinfo/announcement/c/600829_200010.pdf
4,2001-06-12,天鹅股份上市公司章程,/disclosure/listedinfo/announcement/c/600829_2001_g.pdf
5,2001-08-18,天鹅股份半年报,/disclosure/listedinfo/announcement/c/600829_2001_1.pdf
6,2001-09-08,天鹅股份关联交易备查,/disclosure/listedinfo/announcement/c/600829_20010908_1.pdf
7,2001-11-28,天鹅股份关联交易附录,/disclosure/listedinfo/announcement/c/600829_20011128_1.pdf
8,2001-12-25,天鹅股份关联交易备查,/disclosure/listedinfo/announcement/c/600829_20011225_1.pdf
9,2002-04-12,天鹅股份章程修改议案,/disclosure/listedinfo/announcement/c/600829_20020412_1.pdf
10,2002-04-12,天鹅股份信息披露管理办法,/disclosure/listedinfo/announcement/c/600829_20020412_5.pdf
11,2002-04-12,天鹅股份年报,/disclosure/listedinfo/announcement/c/600829_2001_n.pdf
12,2002-04-12,天鹅股份监事会议事规则,/disclosure/listedinfo/announcement/c/600829_20020412_6.pdf
13,2002-04-12,天鹅股份股东大会议事规则,/disclosure/listedinfo/announcement/c/600829_20020412_2.pdf
14,2002-04-12,天鹅股份独立董事工作制度,/disclosure/listedinfo/announcement/c/600829_20020412_4.pdf
15,2002-04-12,天鹅股份董事会议事规则,/disclosure/listedinfo/announcement/c/600829_20020412_3.pdf
16,2002-04-29,天鹅股份第一季度季报,/disclosure/listedinfo/announcement/c/600829_2002_1.pdf
17,2002-08-31,天鹅股份半年报,/disclosure/listedinfo/announcement/c/2002-08-31/600829_2002_z.pdf
18,2002-09-21,天鹅股份股东大会会议资料,/disclosure/listedinfo/announcement/c/2002-09-21/600829_20020921_1.pdf
19,2002-10-09,天鹅股份股东大会决议公告,/disclosure/listedinfo/announcement/c/2002-10-09/600829_20021009_1.pdf
20,2002-10-26,天鹅股份第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-26/600829_2002_3.pdf
21,2003-02-21,天鹅股份关联交易公告,/disclosure/listedinfo/announcement/c/2003-02-21/600829_20030221_1.pdf
22,2003-04-08,天鹅股份年报,/disclosure/listedinfo/announcement/c/2003-04-08/600829_2002_n.pdf
23,2003-04-22,天鹅股份第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-22/600829_2003_1.pdf
24,2003-06-26,天鹅股份股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-06-26/600829_20030626_1.pdf
25,2003-07-01,天鹅股份股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-07-01/600829_20030701_1.pdf
26,2003-08-22,天鹅股份半年报,/disclosure/listedinfo/announcement/c/2003-08-22/600829_2003_z.pdf
27,2003-10-25,天鹅股份第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-25/600829_2003_3.pdf
28,2003-11-06,天鹅股份资产收购、出售备查,/disclosure/listedinfo/announcement/c/2003-11-06/600829_20031106_1.pdf
29,2004-04-20,天鹅股份重大资产重组公告,/disclosure/listedinfo/announcement/c/2004-04-20/600829_20040420_4.pdf
30,2004-04-20,天鹅股份召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-20/600829_20040420_2.pdf
31,2004-04-20,天鹅股份年报,/disclosure/listedinfo/announcement/c/2004-04-20/600829_2003_n.pdf
32,2004-04-20,天鹅股份监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-20/600829_20040420_3.pdf
33,2004-04-20,天鹅股份董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-20/600829_20040420_1.pdf
34,2004-04-26,天鹅股份第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-26/600829_2004_1.pdf
35,2004-04-29,天鹅股份提示性公告,/disclosure/listedinfo/announcement/c/2004-04-29/600829_20040429_1.pdf
36,2004-05-13,天鹅股份2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-13/600829_20040513_1.pdf
37,2004-05-19,天鹅股份董事会决议公告暨延期召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-05-19/600829_20040519_1.pdf
38,2004-05-29,天鹅股份董事会决议公告,/disclosure/listedinfo/announcement/c/2004-05-29/600829_20040529_1.pdf
39,2004-06-08,天鹅股份董事会决议公告暨延期召开2003年度股东大会公告,/disclosure/listedinfo/announcement/c/2004-06-08/600829_20040608_1.pdf
40,2004-06-26,天鹅股份2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-06-26/600829_20040626_1.pdf
41,2004-06-26,天鹅股份2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-06-26/600829_20040626_2.pdf
42,2004-07-15,天鹅股份2004年半年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2004-07-15/600829_20040715_1.pdf
43,2004-07-31,天鹅股份董事会决议公告,/disclosure/listedinfo/announcement/c/2004-07-31/600829_20040731_1.pdf
44,2004-07-31,天鹅股份半年报摘要,/disclosure/listedinfo/announcement/c/2004-07-31/600829_2004_zzy.pdf
45,2004-07-31,天鹅股份半年报,/disclosure/listedinfo/announcement/c/2004-07-31/600829_2004_z.pdf
46,2004-08-19,天鹅股份2003年度资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2004-08-19/600829_20040819_1.pdf
47,2004-09-17,天鹅股份关于股权转让股权过户事项进展情况的提示性公告,/disclosure/listedinfo/announcement/c/2004-09-17/600829_20040917_1.pdf
48,2004-09-25,天鹅股份关于重大资产重组实施结果的公告,/disclosure/listedinfo/announcement/c/2004-09-25/600829_20040925_1.pdf
49,2004-09-29,天鹅股份董事会决议公告,/disclosure/listedinfo/announcement/c/2004-09-29/600829_20040929_1.pdf
50,2004-09-30,天鹅股份关于变更公司名称、住所、经营范围和股票简称的公告,/disclosure/listedinfo/announcement/c/2004-09-30/600829_20040930_1.pdf
51,2004-10-12,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-10-12/600829_20041012_2.pdf
52,2004-10-12,三精制药董事会决议公告暨召开公司临时股东大会通知,/disclosure/listedinfo/announcement/c/2004-10-12/600829_20041012_1.pdf
53,2004-10-12,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-10-12/600829_20041012_3.pdf
54,2004-10-14,三精制药被认定为高新技术企业的公告,/disclosure/listedinfo/announcement/c/2004-10-14/600829_20040114_1.pdf
55,2004-10-25,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-10-25/600829_20041025_1.pdf
56,2004-10-25,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-25/600829_2004_3.pdf
57,2004-10-28,三精制药关于通讯地址和联系方式变更的公告,/disclosure/listedinfo/announcement/c/2004-10-28/600829_20041028_1.pdf
58,2004-11-05,三精制药2004年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-11-05/600829_20041105_1.pdf
59,2004-11-13,三精制药上市公司章程,/disclosure/listedinfo/announcement/c/2004-11-13/600829_20041113_g.pdf
60,2004-11-13,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-11-13/600829_20041113_2.pdf
61,2004-11-13,三精制药2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-11-13/600829_20041113_1.pdf
62,2004-11-13,三精制药2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-11-13/600829_20041113_3.pdf
63,2004-12-08,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-08/600829_20041208_1.pdf
64,2005-02-05,三精制药提取资产减值准备管理制度,/disclosure/listedinfo/announcement/c/2005-02-05/600829_20050205_2.pdf
65,2005-02-05,三精制药坏帐及财产损失核销审批管理制度,/disclosure/listedinfo/announcement/c/2005-02-05/600829_20050205_3.pdf
66,2005-02-05,三精制药董事会决议公告暨召开临时股东大会通知,/disclosure/listedinfo/announcement/c/2005-02-05/600829_20050205_1.pdf
67,2005-02-23,三精制药关于国有股权转让批复的公告,/disclosure/listedinfo/announcement/c/2005-02-23/600829_20050223_1.pdf
68,2005-03-01,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-01/600829_20050301_1.pdf
69,2005-03-02,三精制药2005年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-03-02/600829_20050302_1.pdf
70,2005-03-09,三精制药2005年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-03-09/600829_20050309_1.pdf
71,2005-03-09,三精制药2005年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2005-03-09/600829_20050309_2.pdf
72,2005-03-16,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2005-03-16/600829_2004_nzy.pdf
73,2005-03-16,三精制药年报,/disclosure/listedinfo/announcement/c/2005-03-16/600829_2004_n.pdf
74,2005-03-16,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-16/600829_20050316_2.pdf
75,2005-03-16,三精制药董事会决议公告暨召开公司2004年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-03-16/600829_20050316_1.pdf
76,2005-03-30,三精制药日常关联交易公告,/disclosure/listedinfo/announcement/c/2005-03-30/600829_20050330_2.pdf
77,2005-03-30,三精制药监事会决议暨增加2004年年度股东大会临时提案的公告,/disclosure/listedinfo/announcement/c/2005-03-30/600829_20050330_3.pdf
78,2005-03-30,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-30/600829_20050330_1.pdf
79,2005-04-08,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-08/600829_20050408_2.pdf
80,2005-04-08,三精制药董事会决议公告暨2004年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2005-04-08/600829_20050408_1.pdf
81,2005-04-12,三精制药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-12/600829_20050412_1.pdf
82,2005-04-16,三精制药关于2005年半年度业绩扭亏公告,/disclosure/listedinfo/announcement/c/2005-04-16/600829_20050416_1.pdf
83,2005-04-16,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-16/600829_2005_1.pdf
84,2005-04-19,三精制药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-04-19/600829_20050419_1.pdf
85,2005-04-19,三精制药2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-04-19/600829_20050419_2.pdf
86,2005-05-10,三精制药关联交易公告,/disclosure/listedinfo/announcement/c/2005-05-10/600829_20050510_1.pdf
87,2005-05-10,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-05-10/600829_20050510_2.pdf
88,2005-05-20,三精制药关联交易公告,/disclosure/listedinfo/announcement/c/2005-05-20/600829_20050520_1.pdf
89,2005-05-20,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2005-05-20/600829_20050520_2.pdf
90,2005-05-31,三精制药2004年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-05-31/600829_20050531_1.pdf
91,2005-06-11,三精制药2005年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-06-11/600829_20050611_1.pdf
92,2005-06-17,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2005-06-17/600829_20050617_1.pdf
93,2005-06-21,三精制药2005年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-06-21/600829_20050621_1.pdf
94,2005-06-28,三精制药关联交易公告,/disclosure/listedinfo/announcement/c/2005-06-28/600829_20050628_2.pdf
95,2005-06-28,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2005-06-28/600829_20050628_1.pdf
96,2005-07-07,三精制药关于中国证监会同意豁免哈药集团股份有限公司要约收购义务的公告,/disclosure/listedinfo/announcement/c/2005-07-07/600829_20050707_2.pdf
97,2005-07-07,三精制药关于退还多扣缴的2004年度股息红利个人所得税的公告,/disclosure/listedinfo/announcement/c/2005-07-07/600829_20050707_1.pdf
98,2005-07-22,三精制药2005年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-07-22/600829_20050722_1.pdf
99,2005-07-29,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2005-07-29/600829_20050729_4.pdf
100,2005-07-29,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-07-29/600829_20050729_2.pdf
101,2005-07-29,三精制药2005年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-07-29/600829_20050729_1.pdf
102,2005-07-29,三精制药2005年第三次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-07-29/600829_20050729_3.pdf
103,2005-08-02,三精制药股东增持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-08-02/600829_20050802_1.pdf
104,2005-08-02,三精制药股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-08-02/600829_20050802_2.pdf
105,2005-08-12,三精制药上市公司章程,/disclosure/listedinfo/announcement/c/2005-08-12/600829_20050812_g.pdf
106,2005-08-12,三精制药关于变更公司名称、经营范围的公告,/disclosure/listedinfo/announcement/c/2005-08-12/600829_20050812_1.pdf
107,2005-08-29,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-29/600829_2005_zzy.pdf
108,2005-08-29,三精制药半年报,/disclosure/listedinfo/announcement/c/2005-08-29/600829_2005_z.pdf
109,2005-10-24,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-24/600829_2005_3.pdf
110,2005-10-24,三精制药2005年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2005-10-24/600829_20051024_1.pdf
111,2006-01-11,三精制药关于召开2006年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-01-11/600829_20060111_2.pdf
112,2006-01-11,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-11/600829_20060111_1.pdf
113,2006-02-07,三精制药2006年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-02-07/600829_20060207_1.pdf
114,2006-02-11,三精制药2006年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-02-11/600829_20060211_1.pdf
115,2006-02-11,三精制药2006年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-02-11/600829_20060211_2.pdf
116,2006-02-22,三精制药董事会提示性公告,/disclosure/listedinfo/announcement/c/2006-02-22/600829_20060222_1.pdf
117,2006-03-22,三精制药董事会提示性公告,/disclosure/listedinfo/announcement/c/2006-03-22/600829_20060322_1.pdf
118,2006-04-11,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2006-04-11/600829_20060411_1.pdf
119,2006-04-17,三精制药关于召开Ａ股市场相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_1.pdf
120,2006-04-17,三精制药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_4.pdf
121,2006-04-17,三精制药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_3.pdf
122,2006-04-17,三精制药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_2.pdf
123,2006-04-17,三精制药股权分置改革独立董事意见函,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_6.pdf
124,2006-04-17,三精制药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_5.pdf
125,2006-04-17,三精制药董事会投票委托征集报告书,/disclosure/listedinfo/announcement/c/2006-04-17/600829_20060417_7.pdf
126,2006-04-20,三精制药年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-04-20/600829_2005_nzy.pdf
127,2006-04-20,三精制药年报（修订版）,/disclosure/listedinfo/announcement/c/2006-04-20/600829_2005_n.pdf
128,2006-04-20,三精制药控股股东及其他关联方资金占用情况专项说明,/disclosure/listedinfo/announcement/c/2006-04-20/600829_20060420_3.pdf
129,2006-04-20,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-20/600829_20060420_2.pdf
130,2006-04-20,三精制药董事会决议公告暨召开公司2005年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2006-04-20/600829_20060420_1.pdf
131,2006-04-20,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-20/600829_2006_1.pdf
132,2006-04-24,三精制药关于举办股权分置改革网上交流会的公告,/disclosure/listedinfo/announcement/c/2006-04-24/600829_20060424_1.pdf
133,2006-04-26,三精制药关于延迟披露股权分置改革方案沟通协商情况和结果及延期召开股权分置改革相关股东会议并推迟股权登记日的公告,/disclosure/listedinfo/announcement/c/2006-04-26/600829_20060426_1.pdf
134,2006-05-09,三精制药关于延迟披露股权分置改革方案沟通协商情况和结果及延期召开股权分置改革相关股东会议并推迟股权登记日的公告,/disclosure/listedinfo/announcement/c/2006-05-09/600829_20060509_1.pdf
135,2006-05-16,三精制药关于关联方归还部分占用资金的公告,/disclosure/listedinfo/announcement/c/2006-05-16/600829_20060516_3.pdf
136,2006-05-16,三精制药关于股权分置改革方案股东沟通协商情况和结果的公告,/disclosure/listedinfo/announcement/c/2006-05-16/600829_20060516_2.pdf
137,2006-05-16,三精制药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-16/600829_20060516_5.pdf
138,2006-05-16,三精制药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-05-16/600829_20060516_4.pdf
139,2006-05-16,三精制药2005年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-05-16/600829_20060516_1.pdf
140,2006-05-19,三精制药关于召开股权分置改革A股市场相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-05-19/600829_20060519_1.pdf
141,2006-05-19,三精制药董事会投票委托征集报告书,/disclosure/listedinfo/announcement/c/2006-05-19/600829_20060519_2.pdf
142,2006-05-22,三精制药股票交易异常波动的公告,/disclosure/listedinfo/announcement/c/2006-05-22/600829_20060522_1.pdf
143,2006-05-23,三精制药关于中国证监会同意豁免哈药集团有限公司要约收购义务的公告,/disclosure/listedinfo/announcement/c/2006-05-23/600829_20060523_2.pdf
144,2006-05-23,三精制药2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-23/600829_20060523_1.pdf
145,2006-05-23,三精制药2005年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-23/600829_20060523_3.pdf
146,2006-05-25,三精制药关于召开股权分置改革A股市场相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-05-25/600829_20060525_1.pdf
147,2006-05-31,三精制药股权分置改革相关股东会会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-31/600829_20060531_2.pdf
148,2006-05-31,三精制药A股市场相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-05-31/600829_20060531_1.pdf
149,2006-06-14,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-14/600829_20060614_2.pdf
150,2006-06-14,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-06-14/600829_20060614_1.pdf
151,2006-06-29,三精制药2006年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-06-29/600829_20060629_1.pdf
152,2006-07-01,三精制药关于原关联方归还部分占用资金的公告,/disclosure/listedinfo/announcement/c/2006-07-01/600829_20060701_1.pdf
153,2006-07-05,三精制药2006年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-07-05/600829_20060705_2.pdf
154,2006-07-05,三精制药2006年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-07-05/600829_20060705_3.pdf
155,2006-07-05,三精制药2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-07-05/600829_20060705_1.pdf
156,2006-07-13,三精制药业绩预告修正公告,/disclosure/listedinfo/announcement/c/2006-07-13/600829_20060713_1.pdf
157,2006-07-19,三精制药关于全面完成原关联方占用资金清理回收工作的公告,/disclosure/listedinfo/announcement/c/2006-07-19/600829_20060719_1.pdf
158,2006-07-29,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2006-07-29/600829_20060729_1.pdf
159,2006-07-29,三精制药收购报告书摘要,/disclosure/listedinfo/announcement/c/2006-07-29/600829_20060729_2.pdf
160,2006-07-29,三精制药股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2006-07-29/600829_20060729_3.pdf
161,2006-08-14,三精制药更正性公告,/disclosure/listedinfo/announcement/c/2006-08-14/600829_20060814_1.pdf
162,2006-08-14,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-14/600829_2006_zzy.pdf
163,2006-08-14,三精制药半年报,/disclosure/listedinfo/announcement/c/2006-08-14/600829_2006_z.pdf
164,2006-08-19,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2006-08-19/600829_20060819_1.pdf
165,2006-09-21,三精制药公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-09-21/600829_20060921_g.pdf
166,2006-09-25,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2006-09-25/600829_20060925_1.pdf
167,2006-09-29,三精制药关于召开A股市场相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_1.pdf
168,2006-09-29,三精制药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_4.pdf
169,2006-09-29,三精制药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_3.pdf
170,2006-09-29,三精制药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_2.pdf
171,2006-09-29,三精制药股权分置改革独立董事意见函,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_6.pdf
172,2006-09-29,三精制药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_5.pdf
173,2006-09-29,三精制药董事会投票委托征集报告书,/disclosure/listedinfo/announcement/c/2006-09-29/600829_20060929_7.pdf
174,2006-10-16,S三精关于股权分置改革方案股东沟通协商情况和结果的公告,/disclosure/listedinfo/announcement/c/2006-10-16/600829_20061016_1.pdf
175,2006-10-20,S三精关于召开股权分置改革A股市场相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-10-20/600829_20061020_1.pdf
176,2006-10-23,S三精第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-23/600829_2006_3.pdf
177,2006-10-25,S三精关于股权分置改革方案获国资委批准的公告,/disclosure/listedinfo/announcement/c/2006-10-25/600829_20061025_1.pdf
178,2006-10-26,S三精关于召开股权分置改革A股市场相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-10-26/600829_20061026_1.pdf
179,2006-11-02,S三精股权分置改革相关股东会会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-11-02/600829_20061102_2.pdf
180,2006-11-02,S三精A股市场相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-11-02/600829_20061102_1.pdf
181,2006-11-07,S三精股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-11-07/600829_20061107_1.pdf
182,2006-12-30,三精制药关于中国证监会同意豁免哈药集团有限公司要约收购义务的公告,/disclosure/listedinfo/announcement/c/2006-12-30/600829_20061230_1.pdf
183,2007-01-10,三精制药股票交易异常波动的公告,/disclosure/listedinfo/announcement/c/2007-01-10/600829_20070110_1.pdf
184,2007-01-11,三精制药股权过户完成的提示性公告,/disclosure/listedinfo/announcement/c/2007-01-11/600829_20070111_1.pdf
185,2007-01-18,三精制药股票交易异常波动的公告,/disclosure/listedinfo/announcement/c/2007-01-18/600829_20070118_1.pdf
186,2007-02-03,三精制药为控股子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2007-02-03/600829_20070203_1.pdf
187,2007-02-03,三精制药关于召开公司2007年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-02-03/600829_20070203_2.pdf
188,2007-02-13,三精制药2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-02-13/600829_20070213_1.pdf
189,2007-02-27,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-02-27/600829_20070227_2.pdf
190,2007-02-27,三精制药2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-02-27/600829_20070227_1.pdf
191,2007-02-27,三精制药2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-02-27/600829_20070227_3.pdf
192,2007-04-16,三精制药为控股子公司贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2007-04-16/600829_20070416_2.pdf
193,2007-04-16,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2007-04-16/600829_2006_nzy.pdf
194,2007-04-16,三精制药年报,/disclosure/listedinfo/announcement/c/2007-04-16/600829_2006_n.pdf
195,2007-04-16,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-16/600829_20070416_3.pdf
196,2007-04-16,三精制药董事会决议公告暨召开2006年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-16/600829_20070416_1.pdf
197,2007-04-16,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-16/600829_2007_1.pdf
198,2007-04-16,三精制药大股东及其他关联方资金占用情况专项说明,/disclosure/listedinfo/announcement/c/2007-04-16/600829_20070416_4.pdf
199,2007-04-27,三精制药2006年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-04-27/600829_20070427_1.pdf
200,2007-05-11,三精制药2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-11/600829_20070511_1.pdf
201,2007-05-11,三精制药2006年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-11/600829_20070511_2.pdf
202,2007-05-12,三精制药为控股子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2007-05-12/600829_20070512_1.pdf
203,2007-05-12,三精制药董事会决议公告暨召开公司临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-05-12/600829_20070512_2.pdf
204,2007-05-22,三精制药2007年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-22/600829_20070522_1.pdf
205,2007-05-29,三精制药2007年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600829_20070529_1.pdf
206,2007-05-29,三精制药2007年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-29/600829_20070529_2.pdf
207,2007-07-04,三精制药总经理工作条例,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_3.pdf
208,2007-07-04,三精制药为控股子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_2.pdf
209,2007-07-04,三精制药投资者关系工作制度,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_6.pdf
210,2007-07-04,三精制药董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_4.pdf
211,2007-07-04,三精制药董事会薪酬考核委员会工作细则,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_5.pdf
212,2007-07-04,三精制药董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_7.pdf
213,2007-07-04,三精制药董事会审计委员会工作条例,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_8.pdf
214,2007-07-04,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-07-04/600829_20070704_1.pdf
215,2007-07-17,三精制药2007年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-07-17/600829_20070717_1.pdf
216,2007-07-18,三精制药关于加强上市公司治理专项活动的自查报告及整改计划,/disclosure/listedinfo/announcement/c/2007-07-18/600829_20070718_1.pdf
217,2007-07-21,三精制药2007年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-07-21/600829_20070721_1.pdf
218,2007-07-21,三精制药2007年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-07-21/600829_20070721_2.pdf
219,2007-08-02,三精制药关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2007-08-02/600829_20070802_1.pdf
220,2007-08-11,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-08-11/600829_20070811_1.pdf
221,2007-08-11,三精制药担保公告,/disclosure/listedinfo/announcement/c/2007-08-11/600829_20070811_2.pdf
222,2007-08-16,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-16/600829_2007_zzy.pdf
223,2007-08-16,三精制药半年报,/disclosure/listedinfo/announcement/c/2007-08-16/600829_2007_z.pdf
224,2007-08-24,三精制药2007年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-08-24/600829_20070824_1.pdf
225,2007-08-28,三精制药2007年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-08-28/600829_20070828_1.pdf
226,2007-08-28,三精制药2007年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-08-28/600829_20070828_2.pdf
227,2007-08-30,三精制药关于收购哈药集团制药四厂的关联交易公告,/disclosure/listedinfo/announcement/c/2007-08-30/600829_20070830_2.pdf
228,2007-08-30,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-30/600829_20070830_1.pdf
229,2007-09-22,三精制药对外投资公告,/disclosure/listedinfo/announcement/c/2007-09-22/600829_20070922_2.pdf
230,2007-09-22,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-09-22/600829_20070922_1.pdf
231,2007-09-29,三精制药2007年第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-09-29/600829_20070929_1.pdf
232,2007-10-09,三精制药为控股子公司贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2007-10-09/600829_20071009_3.pdf
233,2007-10-09,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-10-09/600829_20071009_2.pdf
234,2007-10-09,三精制药2007年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-10-09/600829_20071009_1.pdf
235,2007-10-09,三精制药2007年第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-10-09/600829_20071009_4.pdf
236,2007-10-18,三精制药2007年第六次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-10-18/600829_20071018_1.pdf
237,2007-10-23,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-23/600829_2007_3.pdf
238,2007-10-25,三精制药2007年第六次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-10-25/600829_20071025_1.pdf
239,2007-10-25,三精制药2007年第六次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-10-25/600829_20071025_2.pdf
240,2007-10-30,三精制药公司章程（2007修订）,/disclosure/listedinfo/announcement/c/2007-10-30/600829_20071030_g.pdf
241,2007-11-01,三精制药关于公司治理专项活动的整改报告,/disclosure/listedinfo/announcement/c/2007-11-01/600829_20071101_1.pdf
242,2007-11-06,三精制药部分有限售条件股份上市公告,/disclosure/listedinfo/announcement/c/2007-11-06/600829_20071106_1.pdf
243,2007-12-21,三精制药关于终止参股江海证券投资事宜的公告,/disclosure/listedinfo/announcement/c/2007-12-21/600829_20071221_1.pdf
244,2008-01-05,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-01-05/600829_20080105_1.pdf
245,2008-01-19,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-01-19/600829_20080119_1.pdf
246,2008-01-19,三精制药担保公告,/disclosure/listedinfo/announcement/c/2008-01-19/600829_20080119_2.pdf
247,2008-01-29,三精制药2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-01-29/600829_20080129_1.pdf
248,2008-02-05,三精制药2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-02-05/600829_20080205_1.pdf
249,2008-02-05,三精制药2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-02-05/600829_20080205_2.pdf
250,2008-02-21,三精制药关于高管人员辞职的公告,/disclosure/listedinfo/announcement/c/2008-02-21/600829_20080221_1.pdf
251,2008-04-17,三精制药审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_5.pdf
252,2008-04-17,三精制药日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_3.pdf
253,2008-04-17,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2008-04-17/600829_2007_nzy.pdf
254,2008-04-17,三精制药年报,/disclosure/listedinfo/announcement/c/2008-04-17/600829_2007_n.pdf
255,2008-04-17,三精制药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_2.pdf
256,2008-04-17,三精制药独立董事审阅年报工作制度,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_6.pdf
257,2008-04-17,三精制药董事会决议公告暨召开公司2007年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_1.pdf
258,2008-04-17,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-17/600829_2008_1.pdf
259,2008-04-17,三精制药大股东及其他关联方资金占用情况专项说明,/disclosure/listedinfo/announcement/c/2008-04-17/600829_20080417_4.pdf
260,2008-04-30,三精制药2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-04-30/600829_20080430_1.pdf
261,2008-05-09,三精制药2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-09/600829_20080509_1.pdf
262,2008-05-09,三精制药2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-09/600829_20080509_2.pdf
263,2008-05-14,三精制药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-05-14/600829_20080514_1.pdf
264,2008-06-26,三精制药2007年利润分配实施公告,/disclosure/listedinfo/announcement/c/2008-06-26/600829_20080626_1.pdf
265,2008-06-27,三精制药重大信息内部报告制度,/disclosure/listedinfo/announcement/c/2008-06-27/600829_20080627_3.pdf
266,2008-06-27,三精制药突发事件处理制度,/disclosure/listedinfo/announcement/c/2008-06-27/600829_20080627_4.pdf
267,2008-06-27,三精制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-06-27/600829_20080627_2.pdf
268,2008-06-27,三精制药担保公告,/disclosure/listedinfo/announcement/c/2008-06-27/600829_20080627_1.pdf
269,2008-07-08,三精制药2008年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-07-08/600829_20080708_1.pdf
270,2008-07-15,三精制药2008年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-07-15/600829_20080715_1.pdf
271,2008-07-15,三精制药2008年第二次股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-07-15/600829_20080715_2.pdf
272,2008-07-17,三精制药关于公司专项治理整改情况的报告,/disclosure/listedinfo/announcement/c/2008-07-17/600829_20080717_2.pdf
273,2008-07-17,三精制药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-17/600829_20080717_1.pdf
274,2008-08-12,三精制药第五届董事会第十九次会议决议公告暨召开公司2008年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-08-12/600829_20080812_2.pdf
275,2008-08-12,三精制药担保公告,/disclosure/listedinfo/announcement/c/2008-08-12/600829_20080812_1.pdf
276,2008-08-21,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-21/600829_2008_zzy.pdf
277,2008-08-21,三精制药半年报,/disclosure/listedinfo/announcement/c/2008-08-21/600829_2008_z.pdf
278,2008-08-23,三精制药2008年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-08-23/600829_20080823_1.pdf
279,2008-08-28,三精制药2008年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-08-28/600829_20080828_1.pdf
280,2008-08-28,三精制药2008年第三次股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-08-28/600829_20080828_2.pdf
281,2008-10-21,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-21/600829_2008_3.pdf
282,2008-11-04,三精制药有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2008-11-04/600829_20081104_1.pdf
283,2009-01-09,三精制药关于被认定为国家高新技术企业的公告,/disclosure/listedinfo/announcement/c/2009-01-09/600829_20090109_2.pdf
284,2009-01-09,三精制药第五届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-01-09/600829_20090109_1.pdf
285,2009-02-28,三精制药第五届董事会第二十三次会议决议公告暨召开公司2009年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-02-28/600829_20090228_1.pdf
286,2009-02-28,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-02-28/600829_20090228_2.pdf
287,2009-03-12,三精制药2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-12/600829_20090312_1.pdf
288,2009-03-17,三精制药2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-17/600829_20090317_1.pdf
289,2009-03-17,三精制药2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-17/600829_20090317_2.pdf
290,2009-04-17,三精制药审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_6.pdf
291,2009-04-17,三精制药日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_3.pdf
292,2009-04-17,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2009-04-17/600829_2008_nzy.pdf
293,2009-04-17,三精制药年报,/disclosure/listedinfo/announcement/c/2009-04-17/600829_2008_n.pdf
294,2009-04-17,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-17/600829_2009_1.pdf
295,2009-04-17,三精制药第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_2.pdf
296,2009-04-17,三精制药第五届董事会第二十四次会议决议公告暨召开公司2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_1.pdf
297,2009-04-17,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_4.pdf
298,2009-04-17,三精制药2008年度非经营性资金占用及其他关联资金往来情况专项说明,/disclosure/listedinfo/announcement/c/2009-04-17/600829_20090417_5.pdf
299,2009-04-30,三精制药2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-30/600829_20090430_1.pdf
300,2009-05-08,三精制药2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-05-08/600829_20090508_1.pdf
301,2009-05-08,三精制药2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-05-08/600829_20090508_2.pdf
302,2009-06-24,三精制药2008年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-06-24/600829_20090624_1.pdf
303,2009-07-09,三精制药第五届董事会第二十五次会议决议公告暨召开公司2009年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-07-09/600829_20090709_1.pdf
304,2009-07-09,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-07-09/600829_20090709_2.pdf
305,2009-07-21,三精制药2009年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-07-21/600829_20090721_1.pdf
306,2009-07-28,三精制药第五届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2009-07-28/600829_20090728_2.pdf
307,2009-07-28,三精制药2009年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-07-28/600829_20090728_1.pdf
308,2009-07-28,三精制药2009年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-07-28/600829_20090728_3.pdf
309,2009-08-15,三精制药第五届董事会第二十七次会议决议公告暨召开公司2009年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-08-15/600829_20090815_1.pdf
310,2009-08-15,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-08-15/600829_20090815_2.pdf
311,2009-08-24,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-24/600829_2009_zzy.pdf
312,2009-08-24,三精制药半年报,/disclosure/listedinfo/announcement/c/2009-08-24/600829_2009_z.pdf
313,2009-08-27,三精制药2009年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-08-27/600829_20090827_1.pdf
314,2009-09-01,三精制药2009年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-09-01/600829_20090901_1.pdf
315,2009-09-01,三精制药2009年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-09-01/600829_20090901_2.pdf
316,2009-09-16,三精制药公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-09-16/600829_20090916_g.pdf
317,2009-10-17,三精制药第五届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-10-17/600829_20091017_1.pdf
318,2009-10-17,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-17/600829_2009_3.pdf
319,2009-10-17,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-10-17/600829_20091017_2.pdf
320,2009-10-31,三精制药股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2009-10-31/600829_20091031_1.pdf
321,2009-11-14,三精制药第五届董事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2009-11-14/600829_20091114_2.pdf
322,2009-11-14,三精制药担保公告,/disclosure/listedinfo/announcement/c/2009-11-14/600829_20091114_1.pdf
323,2010-02-26,三精制药第五届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-02-26/600829_20100226_2.pdf
324,2010-02-26,三精制药第五届董事会第三十一次会议决议公告暨召开公司2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-02-26/600829_20100226_1.pdf
325,2010-03-09,三精制药2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-03-09/600829_20100309_1.pdf
326,2010-03-16,三精制药第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-16/600829_20100316_3.pdf
327,2010-03-16,三精制药第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-16/600829_20100316_2.pdf
328,2010-03-16,三精制药2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-03-16/600829_20100316_1.pdf
329,2010-03-16,三精制药2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-03-16/600829_20100316_4.pdf
330,2010-04-17,三精制药外部信息报送和使用人管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_6.pdf
331,2010-04-17,三精制药日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_3.pdf
332,2010-04-17,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2010-04-17/600829_2009_nzy.pdf
333,2010-04-17,三精制药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_8.pdf
334,2010-04-17,三精制药年报,/disclosure/listedinfo/announcement/c/2010-04-17/600829_2009_n.pdf
335,2010-04-17,三精制药内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_7.pdf
336,2010-04-17,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-17/600829_2010_1.pdf
337,2010-04-17,三精制药第六届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_2.pdf
338,2010-04-17,三精制药第六届董事会第二次会议决议公告暨召开公司2009年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_1.pdf
339,2010-04-17,三精制药担保公告,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_4.pdf
340,2010-04-17,三精制药2009年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-04-17/600829_20100417_5.pdf
341,2010-04-29,三精制药2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-29/600829_20100429_1.pdf
342,2010-05-11,三精制药2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-05-11/600829_20100511_1.pdf
343,2010-05-11,三精制药2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-05-11/600829_20100511_2.pdf
344,2010-06-22,三精制药2009年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-06-22/600829_20100622_1.pdf
345,2010-06-30,三精制药第六届董事会第三次会议决议公告暨召开公司2010年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-06-30/600829_20100630_1.pdf
346,2010-06-30,三精制药担保公告,/disclosure/listedinfo/announcement/c/2010-06-30/600829_20100630_2.pdf
347,2010-07-07,三精制药2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-07-07/600829_20100707_1.pdf
348,2010-07-17,三精制药关于变更办公地址的公告,/disclosure/listedinfo/announcement/c/2010-07-17/600829_20100717_2.pdf
349,2010-07-17,三精制药2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-07-17/600829_20100717_1.pdf
350,2010-07-17,三精制药2010年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-07-17/600829_20100717_3.pdf
351,2010-08-21,三精制药第六届董事会第四次会议决议公告暨召开公司2010年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-08-21/600829_20100821_1.pdf
352,2010-08-21,三精制药担保公告,/disclosure/listedinfo/announcement/c/2010-08-21/600829_20100821_2.pdf
353,2010-08-21,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-21/600829_2010_zzy.pdf
354,2010-08-21,三精制药半年报,/disclosure/listedinfo/announcement/c/2010-08-21/600829_2010_z.pdf
355,2010-08-31,三精制药2010年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-08-31/600829_20100831_1.pdf
356,2010-09-07,三精制药2010年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-09-07/600829_20100907_1.pdf
357,2010-09-07,三精制药2010年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-09-07/600829_20100907_2.pdf
358,2010-10-19,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-19/600829_2010_3.pdf
359,2010-12-29,三精制药重大事项暨停牌公告,/disclosure/listedinfo/announcement/c/2010-12-29/600829_20101229_1.pdf
360,2011-01-06,三精制药重大事项暨停牌公告,/disclosure/listedinfo/announcement/c/2011-01-06/600829_20110106_1.pdf
361,2011-01-13,三精制药重大事项暨停牌公告,/disclosure/listedinfo/announcement/c/2011-01-13/600829_20110113_1.pdf
362,2011-01-20,三精制药重大事项进展公告,/disclosure/listedinfo/announcement/c/2011-01-20/600829_20110120_1.pdf
363,2011-01-27,三精制药重大事项进展公告,/disclosure/listedinfo/announcement/c/2011-01-27/600829_20110127_1.pdf
364,2011-02-10,三精制药重大事项进展公告,/disclosure/listedinfo/announcement/c/2011-02-10/600829_20110210_1.pdf
365,2011-02-14,三精制药重大事项进展暨延期复牌公告,/disclosure/listedinfo/announcement/c/2011-02-14/600829_20110214_1.pdf
366,2011-02-16,三精制药详式权益变动报告书,/disclosure/listedinfo/announcement/c/2011-02-16/600829_20110216_3.pdf
367,2011-02-16,三精制药提示性公告,/disclosure/listedinfo/announcement/c/2011-02-16/600829_20110216_1.pdf
368,2011-02-16,三精制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2011-02-16/600829_20110216_4.pdf
369,2011-02-16,三精制药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2011-02-16/600829_20110216_2.pdf
370,2011-04-01,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2011-04-01/600829_2010_nzy.pdf
371,2011-04-01,三精制药年报,/disclosure/listedinfo/announcement/c/2011-04-01/600829_2010_n.pdf
372,2011-04-01,三精制药关于2011年度日常关联交易预计及2010年度日常关联交易补充确认的公告,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_3.pdf
373,2011-04-01,三精制药第六届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_2.pdf
374,2011-04-01,三精制药第六届董事会第六次会议决议公告暨召开公司2010年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_1.pdf
375,2011-04-01,三精制药2010年内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_5.pdf
376,2011-04-01,三精制药2010年度社会责任报告,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_6.pdf
377,2011-04-01,三精制药2010年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-04-01/600829_20110401_4.pdf
378,2011-04-14,三精制药2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-04-14/600829_20110414_1.pdf
379,2011-04-22,三精制药2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-04-22/600829_20110422_1.pdf
380,2011-04-22,三精制药2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-04-22/600829_20110422_2.pdf
381,2011-04-26,三精制药第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-26/600829_20110426_1.pdf
382,2011-04-30,三精制药董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-04-30/600829_20110430_3.pdf
383,2011-04-30,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-30/600829_2011_1.pdf
384,2011-04-30,三精制药第六届董事会第八次会议决议公告暨召开公司2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-30/600829_20110430_1.pdf
385,2011-04-30,三精制药担保公告,/disclosure/listedinfo/announcement/c/2011-04-30/600829_20110430_2.pdf
386,2011-05-10,三精制药2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-10/600829_20110510_1.pdf
387,2011-05-12,三精制药第六届董事会第九次会议决议公告暨召开公司2011年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-05-12/600829_20110512_1.pdf
388,2011-05-17,三精制药2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-17/600829_20110517_1.pdf
389,2011-05-17,三精制药2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-05-17/600829_20110517_2.pdf
390,2011-05-20,三精制药2011年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-20/600829_20110520_1.pdf
391,2011-05-28,三精制药2011年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-28/600829_20110528_1.pdf
392,2011-05-28,三精制药2011年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-05-28/600829_20110528_2.pdf
393,2011-06-08,三精制药第六届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2011-06-08/600829_20110608_2.pdf
394,2011-06-08,三精制药2010年度利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2011-06-08/600829_20110608_1.pdf
395,2011-06-15,三精制药公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-06-15/600829_20110615_g.pdf
396,2011-07-16,三精制药第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-16/600829_20110716_1.pdf
397,2011-08-04,三精制药第六届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-04/600829_20110804_1.pdf
398,2011-08-23,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-23/600829_2011_zzy.pdf
399,2011-08-23,三精制药半年报,/disclosure/listedinfo/announcement/c/2011-08-23/600829_2011_z.pdf
400,2011-10-19,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-19/600829_2011_3.pdf
401,2011-11-10,三精制药关于中国证监会并购重组审核委员会审核哈药集团股份有限公司重大资产重组的停牌公告,/disclosure/listedinfo/announcement/c/2011-11-10/600829_20111110_1.pdf
402,2011-11-16,三精制药关于哈药集团股份有限公司重大资产重组获得中国证监会并购重组审核委员会审核通过暨公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2011-11-16/600829_20111116_1.pdf
403,2011-12-08,三精制药内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2011-12-08/600829_20111208_2.pdf
404,2011-12-08,三精制药第六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-08/600829_20111208_1.pdf
405,2011-12-29,三精制药详式权益变动报告书,/disclosure/listedinfo/announcement/c/2011-12-29/600829_20111229_2.pdf
406,2011-12-29,三精制药关于哈药集团股份有限公司发行股份购买资产暨关联交易方案获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2011-12-29/600829_20111229_1.pdf
407,2012-01-10,三精制药关于公司股份转让完成暨控股股东变更的公告,/disclosure/listedinfo/announcement/c/2012-01-10/600829_20120110_2.pdf
408,2012-01-10,三精制药第六届董事会第十六次会议决议公告暨召开公司2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-01-10/600829_20120110_1.pdf
409,2012-01-18,三精制药第六届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2012-01-18/600829_20120118_1.pdf
410,2012-01-20,三精制药2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-01-20/600829_20120120_1.pdf
411,2012-02-03,三精制药2012年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-02-03/600829_20120203_2.pdf
412,2012-02-03,三精制药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-02-03/600829_20120203_1.pdf
413,2012-03-01,三精制药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-03-01/600829_20120301_g.pdf
414,2012-03-31,三精制药第六届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-31/600829_20120331_1.pdf
415,2012-03-31,三精制药2012年内部控制规范体系建设实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-31/600829_20120331_2.pdf
416,2012-04-20,三精制药社会责任报告,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_7.pdf
417,2012-04-20,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2012-04-20/600829_2011_nzy.pdf
418,2012-04-20,三精制药年报,/disclosure/listedinfo/announcement/c/2012-04-20/600829_2011_n.pdf
419,2012-04-20,三精制药关于2012年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_3.pdf
420,2012-04-20,三精制药非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_4.pdf
421,2012-04-20,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-20/600829_2012_1.pdf
422,2012-04-20,三精制药第六届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_2.pdf
423,2012-04-20,三精制药第六届董事会第十九次会议决议公告暨召开公司2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_1.pdf
424,2012-04-20,三精制药2011年内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_6.pdf
425,2012-04-20,三精制药2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-04-20/600829_20120420_5.pdf
426,2012-05-05,三精制药2011年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-05-05/600829_20120505_1.pdf
427,2012-05-16,三精制药2011年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-05-16/600829_20120516_2.pdf
428,2012-05-16,三精制药2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-05-16/600829_20120516_1.pdf
429,2012-05-31,三精制药第六届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-31/600829_20120531_1.pdf
430,2012-07-07,三精制药第六届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-07-07/600829_20120707_2.pdf
431,2012-07-07,三精制药第六届董事会第二十一次会议决议公告暨召开公司2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-07-07/600829_20120707_1.pdf
432,2012-07-17,三精制药2012年上半年内控实施工作进展情况,/disclosure/listedinfo/announcement/c/2012-07-17/600829_20120717_1.pdf
433,2012-07-17,三精制药2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-07-17/600829_20120717_2.pdf
434,2012-07-24,三精制药第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-07-24/600829_20120724_2.pdf
435,2012-07-24,三精制药2012年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-07-24/600829_20120724_3.pdf
436,2012-07-24,三精制药2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-07-24/600829_20120724_1.pdf
437,2012-08-17,三精制药召开2012年第三次临时股东大会通知,/disclosure/listedinfo/announcement/c/2012-08-17/600829_20120817_2.pdf
438,2012-08-17,三精制药第六届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-17/600829_20120817_1.pdf
439,2012-08-17,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-17/600829_2012_zzy.pdf
440,2012-08-17,三精制药半年报,/disclosure/listedinfo/announcement/c/2012-08-17/600829_2012_z.pdf
441,2012-08-28,三精制药2012年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-08-28/600829_20120828_1.pdf
442,2012-09-04,三精制药2012年第三次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-09-04/600829_20120904_2.pdf
443,2012-09-04,三精制药2012年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-09-04/600829_20120904_1.pdf
444,2012-10-08,三精制药关于对全资子公司增资及转让资产的公告,/disclosure/listedinfo/announcement/c/2012-10-08/600829_20121008_2.pdf
445,2012-10-08,三精制药第六届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-08/600829_20121008_1.pdf
446,2012-10-19,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-19/600829_2012_3.pdf
447,2012-10-19,三精制药第六届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-19/600829_20121019_1.pdf
448,2012-10-31,三精制药关于控股股东承诺事项履行情况的公告,/disclosure/listedinfo/announcement/c/2012-10-31/600829_20121031_1.pdf
449,2012-11-22,三精制药第六届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-11-22/600829_20121122_1.pdf
450,2012-12-12,三精制药召开2012年第四次临时股东大会通知,/disclosure/listedinfo/announcement/c/2012-12-12/600829_20121212_2.pdf
451,2012-12-12,三精制药第六届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-12-12/600829_20121212_1.pdf
452,2012-12-21,三精制药2012年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-12-21/600829_20121221_1.pdf
453,2012-12-28,三精制药2012年第四次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-12-27/600829_20121228_2.pdf
454,2012-12-28,三精制药2012年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-12-27/600829_20121228_1.pdf
455,2012-12-29,三精制药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-12-28/600829_20121229_g.pdf
456,2013-01-15,三精制药2012年内控实施工作进展情况,/disclosure/listedinfo/announcement/c/2013-01-14/600829_20130115_1.pdf
457,2013-04-11,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2013-04-10/600829_2012_nzy.pdf
458,2013-04-11,三精制药年报,/disclosure/listedinfo/announcement/c/2013-04-10/600829_2012_n.pdf
459,2013-04-11,三精制药关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_4.pdf
460,2013-04-11,三精制药非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_17.pdf
461,2013-04-11,三精制药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_8.pdf
462,2013-04-11,三精制药独立董事关于对公司2012年度利润分配预案的独立意见2,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_10.pdf
463,2013-04-11,三精制药独立董事关于对公司2012年度利润分配预案的独立意见1,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_9.pdf
464,2013-04-11,三精制药独立董事对第七届董事会董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_7.pdf
465,2013-04-11,三精制药独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_12.pdf
466,2013-04-11,三精制药第六届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_3.pdf
467,2013-04-11,三精制药第六届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_2.pdf
468,2013-04-11,三精制药2013年一季度业绩预减公告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_5.pdf
469,2013-04-11,三精制药2012年社会责任报告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_13.pdf
470,2013-04-11,三精制药2012年内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_14.pdf
471,2013-04-11,三精制药2012年度审计报告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_15.pdf
472,2013-04-11,三精制药2012年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-04-10/600829_20130411_16.pdf
473,2013-04-18,三精制药关于与关联方共同投资设立哈药集团营销有限公司的关联交易公告,/disclosure/listedinfo/announcement/c/2013-04-17/600829_20130418_3.pdf
474,2013-04-18,三精制药独立董事关于与关联方共同投资设立哈药集团营销有限公司的独立意见,/disclosure/listedinfo/announcement/c/2013-04-17/600829_20130418_5.pdf
475,2013-04-18,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-17/600829_2013_1.pdf
476,2013-04-18,三精制药第六届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-17/600829_20130418_2.pdf
477,2013-05-24,三精制药召开2012年年度股东大会通知,/disclosure/listedinfo/announcement/c/2013-05-23/600829_20130524_3.pdf
478,2013-05-24,三精制药关于2013年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2013-05-23/600829_20130524_2.pdf
479,2013-05-24,三精制药第六届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-05-23/600829_20130524_1.pdf
480,2013-05-31,三精制药2012年度业绩说明会预告公告,/disclosure/listedinfo/announcement/c/2013-05-30/600829_20130531_1.pdf
481,2013-06-08,三精制药2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-06-07/600829_20130608_1.pdf
482,2013-06-18,三精制药2012年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2013-06-17/600829_20130618_2.pdf
483,2013-06-18,三精制药2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-06-17/600829_20130618_1.pdf
484,2013-06-19,三精制药独立董事对聘任高管的独立意见,/disclosure/listedinfo/announcement/c/2013-06-18/600829_20130619_3.pdf
485,2013-06-19,三精制药第七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-18/600829_20130619_2.pdf
486,2013-06-19,三精制药第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-18/600829_20130619_1.pdf
487,2013-07-25,三精制药2013年半年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2013-07-24/600829_20130725_1.pdf
488,2013-08-10,三精制药董事会提案管理制度,/disclosure/listedinfo/announcement/c/2013-08-09/600829_20130810_4.pdf
489,2013-08-10,三精制药第七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-09/600829_20130810_2.pdf
490,2013-08-10,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-09/600829_2013_zzy.pdf
491,2013-08-10,三精制药半年报,/disclosure/listedinfo/announcement/c/2013-08-09/600829_2013_z.pdf
492,2013-10-18,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-17/600829_2013_3.pdf
493,2013-12-05,三精制药召开2013年第一次临时股东大会通知,/disclosure/listedinfo/announcement/c/2013-12-04/600829_20131205_2.pdf
494,2013-12-05,三精制药第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-04/600829_20131205_1.pdf
495,2013-12-14,三精制药2013年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-12-13/600829_20131214_1.pdf
496,2013-12-24,三精制药2013年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2013-12-23/600829_20131224_2.pdf
497,2013-12-24,三精制药2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-12-23/600829_20131224_1.pdf
498,2014-01-28,三精制药2013年年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2014-01-27/600829_20140128_1.pdf
499,2014-02-14,三精制药关于控股股东承诺事项履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-13/600829_20140214_1.pdf
500,2014-03-27,三精制药2013年度业绩预告更正公告,/disclosure/listedinfo/announcement/c/2014-03-26/600829_20140327_1.pdf
501,2014-04-03,三精制药召开2013年年度股东大会通知,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_6.pdf
502,2014-04-03,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2014-04-02/600829_2013_nzy.pdf
503,2014-04-03,三精制药年报,/disclosure/listedinfo/announcement/c/2014-04-02/600829_2013_n.pdf
504,2014-04-03,三精制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_5.pdf
505,2014-04-03,三精制药关于2014年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_4.pdf
506,2014-04-03,三精制药股东回报规划（2014-2016）,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_18.pdf
507,2014-04-03,三精制药公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_19.pdf
508,2014-04-03,三精制药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_8.pdf
509,2014-04-03,三精制药独立董事关于公司2014年度日常关联交易预计的意见,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_17.pdf
510,2014-04-03,三精制药独立董事关于对公司2013年度利润分配的独立意见,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_20.pdf
511,2014-04-03,三精制药独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_11.pdf
512,2014-04-03,三精制药董事会审计委员会2013年履职情况报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_16.pdf
513,2014-04-03,三精制药第七届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_3.pdf
514,2014-04-03,三精制药第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_2.pdf
515,2014-04-03,三精制药：关于公司非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_10.pdf
516,2014-04-03,三精制药2013年社会责任报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_13.pdf
517,2014-04-03,三精制药2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_9.pdf
518,2014-04-03,三精制药2013年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_14.pdf
519,2014-04-03,三精制药2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-02/600829_20140403_12.pdf
520,2014-04-18,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-17/600829_2014_1.pdf
521,2014-05-06,三精制药2013年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-05/600829_20140506_1.pdf
522,2014-05-16,三精制药2013年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2014-05-15/600829_20140516_2.pdf
523,2014-05-16,三精制药2013年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-15/600829_20140516_1.pdf
524,2014-05-17,三精制药2013年度社会责任报告,/disclosure/listedinfo/announcement/c/2014-05-16/600829_20140517_1.pdf
525,2014-05-20,三精制药重大事项公告,/disclosure/listedinfo/announcement/c/2014-05-19/600829_20140520_1.pdf
526,2014-05-28,三精制药关于参加“黑龙江辖区上市公司投资者网上集体接待日活动”的公告,/disclosure/listedinfo/announcement/c/2014-05-27/600829_20140528_1.pdf
527,2014-06-07,三精制药关于2013年年报事后审核意见的回复公告,/disclosure/listedinfo/announcement/c/2014-06-06/600829_20140607_1.pdf
528,2014-06-07,三精制药：关于对公司2013年年报的事后审核意见函的回复,/disclosure/listedinfo/announcement/c/2014-06-06/600829_20140607_2.pdf
529,2014-06-13,三精制药关于独立董事张淑芳女士去世的公告,/disclosure/listedinfo/announcement/c/2014-06-12/600829_20140613_1.pdf
530,2014-06-26,三精制药第七届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-06-25/600829_20140626_1.pdf
531,2014-07-07,三精制药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-07-06/600829_20140707_1.pdf
532,2014-08-22,三精制药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-21/600829_2014_zzy.pdf
533,2014-08-22,三精制药半年报,/disclosure/listedinfo/announcement/c/2014-08-21/600829_2014_z.pdf
534,2014-10-16,三精制药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-15/600829_2014_3.pdf
535,2014-10-21,三精制药关于公司会计政策变更的决议公告,/disclosure/listedinfo/announcement/c/2014-10-20/600829_20141021_1.pdf
536,2014-10-21,三精制药独立董事关于公司会计政策变更的独立意见,/disclosure/listedinfo/announcement/c/2014-10-20/600829_20141021_3.pdf
537,2014-10-21,三精制药第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2014-10-20/600829_2014_3.pdf
538,2014-10-21,三精制药第七届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-20/600829_20141021_2.pdf
539,2014-11-20,三精制药涉及诉讼公告,/disclosure/listedinfo/announcement/c/2014-11-19/600829_20141120_1.pdf
540,2014-11-28,三精制药关于仲裁执行进展公告,/disclosure/listedinfo/announcement/c/2014-11-27/600829_20141128_1.pdf
541,2014-12-10,三精制药第七届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-09/600829_20141210_1.pdf
542,2014-12-31,三精制药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-12-30/600829_20141231_1.pdf
543,2015-01-09,三精制药重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2015-01-08/600829_20150109_1.pdf
544,2015-01-14,三精制药关于仲裁结果公告,/disclosure/listedinfo/announcement/c/2015-01-13/600829_20150114_1.pdf
545,2015-01-16,三精制药重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2015-01-15/600829_20150116_1.pdf
546,2015-01-23,三精制药重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-01-22/600829_20150123_1.pdf
547,2015-01-28,三精制药2014年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2015-01-27/600829_20150128_1.pdf
548,2015-01-30,三精制药重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-01-29/600829_20150130_1.pdf
549,2015-02-03,三精制药年报摘要,/disclosure/listedinfo/announcement/c/2015-02-02/600829_2014_nzy.pdf
550,2015-02-03,三精制药年报,/disclosure/listedinfo/announcement/c/2015-02-02/600829_2014_n.pdf
551,2015-02-03,三精制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_7.pdf
552,2015-02-03,三精制药关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_4.pdf
553,2015-02-03,三精制药关于公司执行新会计准则的公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_6.pdf
554,2015-02-03,三精制药关于2015年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_5.pdf
555,2015-02-03,三精制药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_8.pdf
556,2015-02-03,三精制药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_10.pdf
557,2015-02-03,三精制药独立董事关于公司2015年度日常关联交易预计的意见,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_18.pdf
558,2015-02-03,三精制药独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_13.pdf
559,2015-02-03,三精制药董事会审计委员会2014年履职情况报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_17.pdf
560,2015-02-03,三精制药第七届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_3.pdf
561,2015-02-03,三精制药第七届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_20.pdf
562,2015-02-03,三精制药：关于哈药集团三精制药股份有限公司非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_12.pdf
563,2015-02-03,三精制药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_11.pdf
564,2015-02-03,三精制药2014年度社会责任报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_15.pdf
565,2015-02-03,三精制药2014年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_14.pdf
566,2015-02-03,三精制药2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-02-02/600829_20150203_16.pdf
567,2015-02-05,三精制药关于2015年度日常关联交易预计的补充公告,/disclosure/listedinfo/announcement/c/2015-02-04/600829_20150205_1.pdf
568,2015-02-06,三精制药重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-02-05/600829_20150206_1.pdf
569,2015-02-13,三精制药重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-02-12/600829_20150213_1.pdf
570,2015-02-14,三精制药重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2015-02-13/600829_20150214_1.pdf
571,2015-02-17,三精制药重大资产重组进展暨延期复牌公告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_5.pdf
572,2015-02-17,三精制药重大资产置换暨关联交易报告书（草案）摘要,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_1.pdf
573,2015-02-17,三精制药重大资产置换暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_6.pdf
574,2015-02-17,三精制药全体董事、监事、高级管理人员声明与承诺函,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_12.pdf
575,2015-02-17,三精制药拟置出资产模拟财务报表及审计报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_14.pdf
576,2015-02-17,三精制药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_4.pdf
577,2015-02-17,三精制药关于提供信息真实性、准确性和完整性的声明与承诺函,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_11.pdf
578,2015-02-17,三精制药独立董事关于重组报告书的独立意见,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_21.pdf
579,2015-02-17,三精制药独立董事关于评估机构的独立性、评估假设前提的合理性、评估方法与评估目的的相关性以及评估定价的公允性的独立意见,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_20.pdf
580,2015-02-17,三精制药独立董事关于公司重大资产置换暨关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_18.pdf
581,2015-02-17,三精制药独立董事关于公司重大资产置换暨关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_19.pdf
582,2015-02-17,三精制药第七届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_3.pdf
583,2015-02-17,三精制药第七届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_2.pdf
584,2015-02-17,三精制药：哈药集团医药有限公司2013年度、2014年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_8.pdf
585,2015-02-17,三精制药：哈药集团股份有限公司与哈药集团三精制药股份有限公司资产重组涉及的哈药集团三精制药股份有限公司拟置出资产价值项目评估报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_16.pdf
586,2015-02-17,三精制药：哈药集团股份有限公司拟进行资产重组事宜涉及的哈药集团医药有限公司股东全部权益价值评估项目评估报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_9.pdf
587,2015-02-17,三精制药：哈药集团股份有限公司关于提供信息真实性、准确性和完整性的声明与承诺函,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_13.pdf
588,2015-02-17,三精制药：国泰君安证券股份有限公司关于哈药集团三精制药股份有限公司重大资产置换暨关联交易之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_7.pdf
589,2015-02-17,三精制药：国泰君安证券股份有限公司关于《哈药集团三精制药股份有限公司关于重大资产重组信息公布前股票价格波动达到128号文相关标准的说明》之核查意见,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_17.pdf
590,2015-02-17,三精制药：北京大成律师事务所关于哈药集团三精制药股份有限公司重大资产置换暨关联交易之法律意见书,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_10.pdf
591,2015-02-17,三精制药2014年度备考合并财务报表专项审计报告,/disclosure/listedinfo/announcement/c/2015-02-16/600829_20150217_15.pdf
592,2015-02-28,三精制药收到《关于对哈药集团三精制药股份有限公司重大资产置换暨关联交易报告书（草案）的审核意见函》的公告,/disclosure/listedinfo/announcement/c/2015-02-27/600829_20150228_2.pdf
593,2015-02-28,三精制药2014年度业绩说明会预告公告,/disclosure/listedinfo/announcement/c/2015-02-27/600829_20150228_1.pdf
594,2015-03-04,三精制药重大资产重组复牌公告,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_4.pdf
595,2015-03-04,三精制药重大资产置换暨关联交易报告书（草案）摘要（修订稿）,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_8.pdf
596,2015-03-04,三精制药重大资产置换暨关联交易报告书（草案）（修订稿）,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_7.pdf
597,2015-03-04,三精制药关于上海证券交易所《关于对哈药集团三精制药股份有限公司重大资产置换暨关联交易报告书（草案）的审核意见函》回复的公告,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_2.pdf
598,2015-03-04,三精制药关于公司重大资产置换暨关联交易事项获哈尔滨市国资委批复的公告,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_3.pdf
599,2015-03-04,三精制药：国泰君安证券股份有限公司关于上海证券交易所《关于对哈药集团三精制药股份有限公司重大资产置换暨关联交易报告书（草案）的审核意见函》的回复,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_5.pdf
600,2015-03-04,三精制药：国泰君安证券股份有限公司关于哈药集团三精制药股份有限公司重大资产置换暨关联交易之独立财务顾问报告（修订稿）,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_9.pdf
601,2015-03-04,三精制药：北京兴华会计师事务所（特殊普通合伙）关于上海证券交易所《关于对哈药集团三精制药股份有限公司重大资产置换暨关联交易报告书（草案）的审核意见函》的回复,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_6.pdf
602,2015-03-04,三精制药：北京大成律师事务所关于哈药集团三精制药股份有限公司重大资产置换暨关联交易之补充法律意见书（一）,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_10.pdf
603,2015-03-04,三精制药2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-03/600829_20150304_1.pdf
604,2015-03-06,三精制药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-03-05/600829_20150306_1.pdf
605,2015-03-06,三精制药：哈药集团有限公司关于三精制药股票异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-03-05/600829_20150306_3.pdf
606,2015-03-06,三精制药：哈药集团股份有限公司关于三精制药股票异常波动问讯函的回复,/disclosure/listedinfo/announcement/c/2015-03-05/600829_20150306_2.pdf
607,2015-03-07,三精制药关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-03-06/600829_20150307_2.pdf
608,2015-03-07,三精制药关于网上业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2015-03-06/600829_20150307_1.pdf
609,2015-03-07,三精制药2014年度业绩说明会会议纪要,/disclosure/listedinfo/announcement/c/2015-03-06/600829_20150307_3.pdf
610,2015-03-13,三精制药重大资产置换暨关联交易报告书摘要,/disclosure/listedinfo/announcement/c/2015-03-12/600829_20150313_4.pdf
611,2015-03-13,三精制药重大资产置换暨关联交易报告书,/disclosure/listedinfo/announcement/c/2015-03-12/600829_20150313_3.pdf
612,2015-03-13,三精制药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-12/600829_20150313_1.pdf
613,2015-03-13,三精制药2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-12/600829_20150313_2.pdf
614,2015-03-14,三精制药关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_6.pdf
615,2015-03-14,三精制药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_5.pdf
616,2015-03-14,三精制药关于设立全资子公司及后续资产注入的公告,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_4.pdf
617,2015-03-14,三精制药关于公司董事、监事辞职的公告,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_1.pdf
618,2015-03-14,三精制药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_8.pdf
619,2015-03-14,三精制药独立董事对董事会董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_7.pdf
620,2015-03-14,三精制药第七届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_3.pdf
621,2015-03-14,三精制药第七届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-13/600829_20150314_2.pdf
622,2015-03-21,三精制药年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2015-03-20/600829_2014_nzy.pdf
623,2015-03-21,三精制药年报（修订版）,/disclosure/listedinfo/announcement/c/2015-03-20/600829_2014_n.pdf
624,2015-03-21,三精制药关于2014年年度报告及年报摘要的补充公告,/disclosure/listedinfo/announcement/c/2015-03-20/600829_20150321_2.pdf
625,2015-03-21,三精制药关于2014年年报事后审核意见回复的公告,/disclosure/listedinfo/announcement/c/2015-03-20/600829_20150321_1.pdf
626,2015-03-21,三精制药：关于对哈药集团三精制药股份有限公司2014年年报的事后审核意见函的回复,/disclosure/listedinfo/announcement/c/2015-03-20/600829_20150321_3.pdf
627,2015-03-21,三精制药：《关于对哈药集团三精制药股份有限公司2014年年报的事后审核意见函》相关事项的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-20/600829_20150321_4.pdf
628,2015-03-21,三精制药2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-20/600829_20150321_7.pdf
629,2015-03-26,三精制药重大资产置换暨关联交易实施情况报告书,/disclosure/listedinfo/announcement/c/2015-03-25/600829_20150326_4.pdf
630,2015-03-26,三精制药关于重大资产重组相关资产完成交割的公告,/disclosure/listedinfo/announcement/c/2015-03-25/600829_20150326_1.pdf
631,2015-03-26,三精制药：国泰君安证券股份有限公司关于哈药集团三精制药股份有限公司重大资产置换暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-03-25/600829_20150326_2.pdf
632,2015-03-26,三精制药：北京大成律师事务所关于哈药集团三精制药股份有限公司重大资产置换暨关联交易之实施情况的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-25/600829_20150326_3.pdf
633,2015-03-31,三精制药关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_5.pdf
634,2015-03-31,三精制药关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_2.pdf
635,2015-03-31,三精制药关于董事会秘书、证券事务代表辞职及聘任新董事会秘书的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_3.pdf
636,2015-03-31,三精制药独立董事对聘任高管的独立意见,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_8.pdf
637,2015-03-31,三精制药第七届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_6.pdf
638,2015-03-31,三精制药第七届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_4.pdf
639,2015-03-31,三精制药2015年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_7.pdf
640,2015-03-31,三精制药2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600829_20150331_1.pdf
641,2015-04-16,三精制药关于变更公司名称的公告,/disclosure/listedinfo/announcement/c/2015-04-15/600829_20150416_1.pdf
642,2015-04-18,三精制药关于变更公司证券简称、办公地址及投资者联系方式的公告,/disclosure/listedinfo/announcement/c/2015-04-17/600829_20150418_1.pdf
643,2015-04-22,三精制药关于同一控制下企业合并追溯调整财务数据的公告,/disclosure/listedinfo/announcement/c/2015-04-21/600829_20150422_3.pdf
644,2015-04-22,三精制药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-21/600829_2015_1.pdf
645,2015-04-22,三精制药第七届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-21/600829_20150422_2.pdf
646,2015-06-02,人民同泰总经理工作条例,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_21.pdf
647,2015-06-02,人民同泰重大信息内部报告制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_7.pdf
648,2015-06-02,人民同泰信息披露管理制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_13.pdf
649,2015-06-02,人民同泰外部信息报送和使用人管理制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_8.pdf
650,2015-06-02,人民同泰突发事件处理管理制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_6.pdf
651,2015-06-02,人民同泰投资者关系工作制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_5.pdf
652,2015-06-02,人民同泰审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_18.pdf
653,2015-06-02,人民同泰年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_25.pdf
654,2015-06-02,人民同泰内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_24.pdf
655,2015-06-02,人民同泰监事会议事规则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_9.pdf
656,2015-06-02,人民同泰关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_4.pdf
657,2015-06-02,人民同泰关于2015年度日常关联交易预计调整的公告,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_3.pdf
658,2015-06-02,人民同泰股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_11.pdf
659,2015-06-02,人民同泰独立董事制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_19.pdf
660,2015-06-02,人民同泰独立董事审阅年报工作制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_20.pdf
661,2015-06-02,人民同泰独立董事关于公司2015年度日常关联交易预计调整的意见,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_10.pdf
662,2015-06-02,人民同泰董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_14.pdf
663,2015-06-02,人民同泰董事会议事规则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_12.pdf
664,2015-06-02,人民同泰董事会薪酬与考核委员会工作细则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_16.pdf
665,2015-06-02,人民同泰董事会提名委员会工作细则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_15.pdf
666,2015-06-02,人民同泰董事会提案管理制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_23.pdf
667,2015-06-02,人民同泰董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_17.pdf
668,2015-06-02,人民同泰董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_22.pdf
669,2015-06-02,人民同泰第七届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_2.pdf
670,2015-06-02,人民同泰第七届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-01/600829_20150602_1.pdf
671,2015-06-13,人民同泰股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-06-12/600829_20150613_1.pdf
672,2015-06-13,人民同泰：哈药集团有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-06-12/600829_20150613_3.pdf
673,2015-06-13,人民同泰：哈药集团股份有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-06-12/600829_20150613_2.pdf
674,2015-06-18,人民同泰2015年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-17/600829_20150618_1.pdf
675,2015-06-27,人民同泰2015年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2015-06-26/600829_20150627_2.pdf
676,2015-06-27,人民同泰2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-26/600829_20150627_1.pdf
677,2015-07-07,人民同泰股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-06/600829_20150707_1.pdf
678,2015-07-07,人民同泰：哈药集团有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-06/600829_20150707_3.pdf
679,2015-07-07,人民同泰：哈药集团股份有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-06/600829_20150707_2.pdf
680,2015-07-11,人民同泰关于召开投资者说明会的公告,/disclosure/listedinfo/announcement/c/2015-07-10/600829_20150711_2.pdf
681,2015-07-11,人民同泰关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-10/600829_20150711_1.pdf
682,2015-07-14,人民同泰关于公司董事长增持本公司股票的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600829_20150714_1.pdf
683,2015-07-15,人民同泰股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-14/600829_20150715_1.pdf
684,2015-07-15,人民同泰：哈药集团有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-14/600829_20150715_2.pdf
685,2015-07-15,人民同泰：哈药集团股份有限公司关于人民同泰股票交易异常波动问询函的回复,/disclosure/listedinfo/announcement/c/2015-07-14/600829_20150715_3.pdf
686,2015-08-15,人民同泰半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-15/600829_2015_zzy.pdf
687,2015-08-15,人民同泰半年报,/disclosure/listedinfo/announcement/c/2015-08-15/600829_2015_z.pdf
688,2015-08-29,人民同泰关于公司高级管理人员增持本公司股票的公告,/disclosure/listedinfo/announcement/c/2015-08-29/600829_20150829_1.pdf
689,2015-10-24,人民同泰关于公司2015年1-3季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2015-10-24/600829_20151024_2.pdf
690,2015-10-24,人民同泰第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-24/600829_2015_3.pdf
691,2015-12-10,人民同泰关于公司独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-12-10/600829_20151210_1.pdf
692,2015-12-23,人民同泰关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-12-23/600829_20151223_2.pdf
693,2015-12-23,人民同泰独立董事对第七届董事会独立董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2015-12-23/600829_20151223_3.pdf
694,2015-12-23,人民同泰第七届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-23/600829_20151223_1.pdf
695,2015-12-31,人民同泰2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-12-31/600829_20151231_1.pdf
696,2016-01-06,人民同泰关于公司高级管理人员退休的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600829_20160106_1.pdf
697,2016-01-09,人民同泰2016年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2016-01-09/600829_20160109_2.pdf
698,2016-01-09,人民同泰2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-01-09/600829_20160109_1.pdf
699,2016-01-30,人民同泰年报摘要,/disclosure/listedinfo/announcement/c/2016-01-30/600829_2015_nzy.pdf
700,2016-01-30,人民同泰年报,/disclosure/listedinfo/announcement/c/2016-01-30/600829_2015_n.pdf
701,2016-01-30,人民同泰关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_5.pdf
702,2016-01-30,人民同泰关于股东对置入资产2015年度业绩承诺实现情况的说明审核报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_12.pdf
703,2016-01-30,人民同泰关于2016年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_4.pdf
704,2016-01-30,人民同泰独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_6.pdf
705,2016-01-30,人民同泰独立董事关于公司2016年度日常关联交易预计的意见,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_16.pdf
706,2016-01-30,人民同泰独立董事关于对公司2015年度利润分配的独立意见,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_15.pdf
707,2016-01-30,人民同泰独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_10.pdf
708,2016-01-30,人民同泰董事会审计委员会2015年履职情况报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_14.pdf
709,2016-01-30,人民同泰第七届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_3.pdf
710,2016-01-30,人民同泰第七届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_2.pdf
711,2016-01-30,人民同泰：关于哈药集团人民同泰医药股份有限公司非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_9.pdf
712,2016-01-30,人民同泰2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_8.pdf
713,2016-01-30,人民同泰2015年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_13.pdf
714,2016-01-30,人民同泰2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-01-30/600829_20160130_11.pdf
715,2016-02-02,人民同泰关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2016-02-02/600829_20160202_1.pdf
716,2016-02-02,人民同泰独立董事关于续聘会计师事务所的独立意见,/disclosure/listedinfo/announcement/c/2016-02-02/600829_20160202_3.pdf
717,2016-02-02,人民同泰：国泰君安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产置换之2015年度持续督导工作报告书,/disclosure/listedinfo/announcement/c/2016-02-02/600829_20160202_2.pdf
718,2016-02-02,人民同泰：国泰君安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产置换2015年度业绩承诺实现情况的核查意见,/disclosure/listedinfo/announcement/c/2016-02-02/600829_20160202_4.pdf
719,2016-03-11,人民同泰2015年度业绩说明会预告公告,/disclosure/listedinfo/announcement/c/2016-03-11/600829_20160311_1.pdf
720,2016-03-17,人民同泰关于网上业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2016-03-17/600829_20160317_1.pdf
721,2016-03-17,人民同泰关于收到上海证券交易所对公司2015年年度报告的事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2016-03-17/600829_20160317_2.pdf
722,2016-03-17,人民同泰2015年度业绩说明会会议纪要,/disclosure/listedinfo/announcement/c/2016-03-17/600829_20160317_3.pdf
723,2016-03-26,人民同泰关于上海证券交易所对公司2015年年度报告事后审核问询函回复的公告,/disclosure/listedinfo/announcement/c/2016-03-26/600829_20160326_1.pdf
724,2016-03-29,人民同泰关于公司高级管理人员退休的公告,/disclosure/listedinfo/announcement/c/2016-03-29/600829_20160329_1.pdf
725,2016-04-23,人民同泰关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-23/600829_20160423_4.pdf
726,2016-04-23,人民同泰关于公司2016年第一季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-04-23/600829_20160423_3.pdf
727,2016-04-23,人民同泰第七届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-23/600829_20160423_2.pdf
728,2016-04-23,人民同泰2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-23/600829_2016_1.pdf
729,2016-05-06,人民同泰2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-05-06/600829_20160506_1.pdf
730,2016-05-19,人民同泰2015年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2016-05-19/600829_20160519_2.pdf
731,2016-05-19,人民同泰2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-19/600829_20160519_1.pdf
732,2016-06-08,人民同泰第七届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600829_20160608_1.pdf
733,2016-07-05,人民同泰关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-07-05/600829_20160705_3.pdf
734,2016-07-05,人民同泰独立董事对董事会董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2016-07-05/600829_20160705_4.pdf
735,2016-07-05,人民同泰第七届监事会第十九次会议公告,/disclosure/listedinfo/announcement/c/2016-07-05/600829_20160705_2.pdf
736,2016-07-05,人民同泰第七届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-05/600829_20160705_1.pdf
737,2016-07-14,人民同泰2016年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-07-14/600829_20160714_1.pdf
738,2016-07-22,人民同泰关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_4.pdf
739,2016-07-22,人民同泰独立董事对聘任高管的独立意见,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_6.pdf
740,2016-07-22,人民同泰第八届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_3.pdf
741,2016-07-22,人民同泰第八届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_2.pdf
742,2016-07-22,人民同泰2016年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_5.pdf
743,2016-07-22,人民同泰2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-07-22/600829_20160722_1.pdf
744,2016-08-02,人民同泰关于公司总经理辞职的公告,/disclosure/listedinfo/announcement/c/2016-08-02/600829_20160802_1.pdf
745,2016-08-05,人民同泰关于公司2016年半年度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-08-05/600829_20160805_2.pdf
746,2016-08-05,人民同泰2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-05/600829_2016_zzy.pdf
747,2016-08-05,人民同泰2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-05/600829_2016_z.pdf
748,2016-09-27,人民同泰独立董事对聘任总经理及增补董事的独立意见,/disclosure/listedinfo/announcement/c/2016-09-27/600829_20160927_2.pdf
749,2016-09-27,人民同泰第八届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-27/600829_20160927_1.pdf
750,2016-10-21,人民同泰关于召开2016年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-10-21/600829_20161021_3.pdf
751,2016-10-21,人民同泰关于公司2016年1-3季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-10-21/600829_20161021_4.pdf
752,2016-10-21,人民同泰第八届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-21/600829_20161021_2.pdf
753,2016-10-21,人民同泰2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-21/600829_2016_3.pdf
754,2016-11-01,人民同泰2016年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-01/600829_20161101_1.pdf
755,2016-11-10,人民同泰2016年第三次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2016-11-10/600829_20161110_2.pdf
756,2016-11-10,人民同泰2016年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-11-10/600829_20161110_1.pdf
757,2017-01-12,人民同泰关于公司诉讼进展的公告,/disclosure/listedinfo/announcement/c/2017-01-12/600829_20170112_1.pdf
758,2017-01-26,人民同泰关于子公司签署拆迁补偿协议的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600829_20170126_1.pdf
759,2017-01-26,人民同泰2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-26/600829_20170126_2.pdf
760,2017-02-16,人民同泰关于子公司签署拆迁补偿协议的进展公告,/disclosure/listedinfo/announcement/c/2017-02-16/600829_20170216_1.pdf
761,2017-02-25,人民同泰信息披露暂缓与豁免业务管理制度,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_28.pdf
762,2017-02-25,人民同泰关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_6.pdf
763,2017-02-25,人民同泰关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_9.pdf
764,2017-02-25,人民同泰关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_4.pdf
765,2017-02-25,人民同泰关于计提预计负债的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_7.pdf
766,2017-02-25,人民同泰关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_8.pdf
767,2017-02-25,人民同泰关于2017年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_5.pdf
768,2017-02-25,人民同泰股东回报规划（2017-2019）,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_29.pdf
769,2017-02-25,人民同泰公司章程（2017年2月修订）,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_30.pdf
770,2017-02-25,人民同泰独立董事关于续聘会计师事务所的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_26.pdf
771,2017-02-25,人民同泰独立董事关于经营者薪酬方案的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_25.pdf
772,2017-02-25,人民同泰独立董事关于计提资产减值准备的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_27.pdf
773,2017-02-25,人民同泰独立董事关于计提预计负债的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_24.pdf
774,2017-02-25,人民同泰独立董事关于会计政策变更的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_23.pdf
775,2017-02-25,人民同泰独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_11.pdf
776,2017-02-25,人民同泰独立董事关于公司2017年度日常关联交易预计的意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_22.pdf
777,2017-02-25,人民同泰独立董事关于对公司股东回报规划的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_21.pdf
778,2017-02-25,人民同泰独立董事关于对公司2017年度日常关联交易预计事项事前认可的意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_20.pdf
779,2017-02-25,人民同泰独立董事关于对公司2016年度利润分配的独立意见,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_19.pdf
780,2017-02-25,人民同泰独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_14.pdf
781,2017-02-25,人民同泰董事会审计委员会2016年履职情况报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_18.pdf
782,2017-02-25,人民同泰第八届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_3.pdf
783,2017-02-25,人民同泰第八届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_2.pdf
784,2017-02-25,人民同泰：关于哈药集团人民同泰医药股份有限公司非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_13.pdf
785,2017-02-25,人民同泰：关于股东对置入资产2016年度业绩承诺实现情况的说明审核报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_16.pdf
786,2017-02-25,人民同泰：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_12.pdf
787,2017-02-25,人民同泰：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_17.pdf
788,2017-02-25,人民同泰2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-02-25/600829_2016_nzy.pdf
789,2017-02-25,人民同泰2016年年度报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_2016_n.pdf
790,2017-02-25,人民同泰2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-02-25/600829_20170225_15.pdf
791,2017-03-01,人民同泰关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-01/600829_20170301_1.pdf
792,2017-03-10,人民同泰：国泰君安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产置换之2016年度持续督导工作报告暨持续督导总结报告,/disclosure/listedinfo/announcement/c/2017-03-10/600829_20170310_1.pdf
793,2017-03-10,人民同泰：国泰君安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产置换2016年度业绩承诺实现情况的核查意见,/disclosure/listedinfo/announcement/c/2017-03-10/600829_20170310_2.pdf
794,2017-03-11,人民同泰2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-03-11/600829_20170311_1.pdf
795,2017-03-24,人民同泰2016年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2017-03-24/600829_20170324_2.pdf
796,2017-03-24,人民同泰2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-03-24/600829_20170324_1.pdf
797,2017-04-06,人民同泰2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-04-06/600829_20170406_1.pdf
798,2017-04-13,人民同泰关于公司2017年第一季度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2017-04-13/600829_20170413_2.pdf
799,2017-04-13,人民同泰第八届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-13/600829_20170413_3.pdf
800,2017-04-13,人民同泰2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-13/600829_2017_1.pdf
801,2017-05-27,人民同泰子公司申请委托贷款展期暨关联交易公告,/disclosure/listedinfo/announcement/c/2017-05-27/600829_20170527_2.pdf
802,2017-05-27,人民同泰关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-27/600829_20170527_4.pdf
803,2017-05-27,人民同泰独立董事关于子公司接受委托贷款暨关联交易的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-05-27/600829_20170527_3.pdf
804,2017-05-27,人民同泰第八届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-27/600829_20170527_1.pdf
805,2017-06-03,人民同泰关于关联方资金占用的自查说明和整改情况公告,/disclosure/listedinfo/announcement/c/2017-06-03/600829_20170603_1.pdf
806,2017-06-06,人民同泰关于控股股东的股东股权结构变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-06/600829_20170606_3.pdf
807,2017-06-06,人民同泰2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-06/600829_20170606_1.pdf
808,2017-06-08,人民同泰关于收到中信资本控股有限公司说明函的公告,/disclosure/listedinfo/announcement/c/2017-06-08/600829_20170608_1.pdf
809,2017-06-10,人民同泰关于收到关联方归还非经营性资金占用的公告,/disclosure/listedinfo/announcement/c/2017-06-10/600829_20170610_1.pdf
810,2017-06-14,人民同泰2017年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2017-06-14/600829_20170614_2.pdf
811,2017-06-14,人民同泰2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-14/600829_20170614_1.pdf
812,2017-07-05,人民同泰第八届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-05/600829_20170705_1.pdf
813,2017-07-29,人民同泰2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-07-29/600829_2017_zzy.pdf
814,2017-07-29,人民同泰2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-07-29/600829_2017_z.pdf
815,2017-08-11,人民同泰关于设立子公司暨关联交易公告,/disclosure/listedinfo/announcement/c/2017-08-11/600829_20170811_1.pdf
816,2017-08-11,人民同泰独立董事关于与关联方共同出资设立哈药集团人民医药连锁有限公司的独立意见,/disclosure/listedinfo/announcement/c/2017-08-11/600829_20170811_2.pdf
817,2017-08-11,人民同泰第八届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-11/600829_20170811_3.pdf
818,2017-09-28,人民同泰重大事项停牌公告,/disclosure/listedinfo/announcement/c/2017-09-28/600829_20170928_1.pdf
819,2017-10-12,人民同泰重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2017-10-12/600829_20171012_2.pdf
820,2017-10-12,人民同泰第八届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-12/600829_20171012_1.pdf
821,2017-10-17,人民同泰关于重大诉讼终审判决的公告,/disclosure/listedinfo/announcement/c/2017-10-17/600829_20171017_1.pdf
822,2017-10-18,人民同泰关于重大诉讼终审判决的补充公告,/disclosure/listedinfo/announcement/c/2017-10-18/600829_20171018_1.pdf
823,2017-10-19,人民同泰重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2017-10-19/600829_20171019_2.pdf
824,2017-10-19,人民同泰重大事项进展公告,/disclosure/listedinfo/announcement/c/2017-10-19/600829_20171019_1.pdf
825,2017-10-20,人民同泰重大资产重组停牌前股东持股情况公告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_20171020_7.pdf
826,2017-10-20,人民同泰关于收到拆迁补偿款的公告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_20171020_6.pdf
827,2017-10-20,人民同泰关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_20171020_1.pdf
828,2017-10-20,人民同泰第八届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_20171020_5.pdf
829,2017-10-20,人民同泰第八届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_20171020_4.pdf
830,2017-10-20,人民同泰2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-20/600829_2017_3.pdf
831,2017-10-26,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-10-26/600829_20171026_1.pdf
832,2017-10-28,人民同泰重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2017-10-28/600829_20171028_1.pdf
833,2017-11-02,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-02/600829_20171102_1.pdf
834,2017-11-09,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-09/600829_20171109_2.pdf
835,2017-11-09,人民同泰关于董事长到龄退休公告,/disclosure/listedinfo/announcement/c/2017-11-09/600829_20171109_1.pdf
836,2017-11-14,人民同泰关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-11-14/600829_20171114_1.pdf
837,2017-11-14,人民同泰独立董事关于增补董事的独立意见,/disclosure/listedinfo/announcement/c/2017-11-14/600829_20171114_3.pdf
838,2017-11-14,人民同泰第八届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-14/600829_20171114_2.pdf
839,2017-11-16,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-16/600829_20171116_1.pdf
840,2017-11-23,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-23/600829_20171123_2.pdf
841,2017-11-23,人民同泰2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-23/600829_20171123_1.pdf
842,2017-11-28,人民同泰重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2017-11-28/600829_20171128_2.pdf
843,2017-11-28,人民同泰第八届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-28/600829_20171128_1.pdf
844,2017-11-30,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-30/600829_20171130_4.pdf
845,2017-11-30,人民同泰第八届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-30/600829_20171130_3.pdf
846,2017-11-30,人民同泰2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-30/600829_20171130_1.pdf
847,2017-11-30,人民同泰2017年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-11-30/600829_20171130_2.pdf
848,2017-12-07,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-12-07/600829_20171207_1.pdf
849,2017-12-11,人民同泰关于召开2017年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-11/600829_20171211_1.pdf
850,2017-12-11,人民同泰独立董事关于公司重大资产重组继续停牌的独立意见,/disclosure/listedinfo/announcement/c/2017-12-11/600829_20171211_3.pdf
851,2017-12-11,人民同泰第八届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-11/600829_20171211_2.pdf
852,2017-12-14,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-12-14/600829_20171214_1.pdf
853,2017-12-19,人民同泰2017年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-19/600829_20171219_1.pdf
854,2017-12-21,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-12-21/600829_20171221_2.pdf
855,2017-12-21,人民同泰关于召开重大资产重组投资者说明会预告公告,/disclosure/listedinfo/announcement/c/2017-12-21/600829_20171221_1.pdf
856,2017-12-23,人民同泰重大事项进展及提示性公告,/disclosure/listedinfo/announcement/c/2017-12-23/600829_20171223_2.pdf
857,2017-12-23,人民同泰关于重大资产重组投资者说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2017-12-23/600829_20171223_1.pdf
858,2017-12-23,人民同泰关于控股股东的股东股权结构变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-23/600829_20171223_3.pdf
859,2017-12-27,人民同泰2017年第三次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2017-12-27/600829_20171227_2.pdf
860,2017-12-27,人民同泰2017年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-27/600829_20171227_1.pdf
861,2017-12-28,人民同泰要约收购报告书摘要,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_5.pdf
862,2017-12-28,人民同泰简式权益变动报告书,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_3.pdf
863,2017-12-28,人民同泰关于重大资产重组继续停牌暨进展的公告,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_1.pdf
864,2017-12-28,人民同泰关于收到要约收购报告书摘要的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_6.pdf
865,2017-12-28,人民同泰关于公司实际控制人拟发生变更的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_2.pdf
866,2017-12-28,人民同泰：平安证券股份有限公司关于中信资本股权投资（天津）股份有限公司要约收购哈药集团人民同泰医药股份有限公司之财务顾问报告,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_8.pdf
867,2017-12-28,人民同泰：平安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产重组延期复牌的核查意见,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_4.pdf
868,2017-12-28,人民同泰：北京市君合律师事务所关于《哈药集团人民同泰医药股份有限公司要约收购报告书摘要》的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-28/600829_20171228_7.pdf
869,2017-12-29,人民同泰关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600829_20171229_1.pdf
870,2018-01-04,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-01-04/600829_20180104_1.pdf
871,2018-01-05,人民同泰关于延期回复上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2018-01-05/600829_20180105_1.pdf
872,2018-01-10,人民同泰要约收购报告书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2018-01-10/600829_20180110_2.pdf
873,2018-01-10,人民同泰关于上海证券交易所《关于对人民同泰实际控制人拟发生变更等事项的问询函》的回复公告,/disclosure/listedinfo/announcement/c/2018-01-10/600829_20180110_1.pdf
874,2018-01-10,人民同泰：平安证券关于《上海证券交易所关于对人民同泰实际控制人拟发生变更等事项的问询函》之专项核查意见,/disclosure/listedinfo/announcement/c/2018-01-10/600829_20180110_3.pdf
875,2018-01-11,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-01-11/600829_20180111_1.pdf
876,2018-01-12,人民同泰关于哈药集团增资事宜获得哈尔滨市人民政府批复的公告,/disclosure/listedinfo/announcement/c/2018-01-12/600829_20180112_1.pdf
877,2018-01-18,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-01-18/600829_20180118_1.pdf
878,2018-01-25,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-01-25/600829_20180125_1.pdf
879,2018-01-27,人民同泰重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2018-01-27/600829_20180127_1.pdf
880,2018-01-27,人民同泰：平安证券股份有限公司关于哈药集团人民同泰医药股份有限公司重大资产重组停牌期间重组进展信息披露的真实性、继续停牌的合理性和5个月内复牌可行性的专项核查意见,/disclosure/listedinfo/announcement/c/2018-01-27/600829_20180127_2.pdf
881,2018-01-30,人民同泰章程（2018年1月修订）,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_21.pdf
882,2018-01-30,人民同泰关于追加2017年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_14.pdf
883,2018-01-30,人民同泰关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_17.pdf
884,2018-01-30,人民同泰关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_20.pdf
885,2018-01-30,人民同泰关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_18.pdf
886,2018-01-30,人民同泰关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_19.pdf
887,2018-01-30,人民同泰关于公司2018年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_16.pdf
888,2018-01-30,人民同泰独立董事关于公司关联交易的独立意见,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_15.pdf
889,2018-01-30,人民同泰独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_3.pdf
890,2018-01-30,人民同泰独立董事关于第八届董事会第十八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_11.pdf
891,2018-01-30,人民同泰独立董事2017年度述职报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_6.pdf
892,2018-01-30,人民同泰董事会审计委员会2017年度履职报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_10.pdf
893,2018-01-30,人民同泰第八届监事会第八次会议决议,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_13.pdf
894,2018-01-30,人民同泰第八届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_12.pdf
895,2018-01-30,人民同泰：非经营性资金占用及其他关联资金往来的专项说明,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_5.pdf
896,2018-01-30,人民同泰：2017年度业绩承诺审计报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_8.pdf
897,2018-01-30,人民同泰：2017年度审计报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_4.pdf
898,2018-01-30,人民同泰：2017年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_9.pdf
899,2018-01-30,人民同泰2017年年度报告摘要,/disclosure/listedinfo/announcement/c/2018-01-30/600829_2017_nzy.pdf
900,2018-01-30,人民同泰2017年年度报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_2017_n.pdf
901,2018-01-30,人民同泰2017年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2018-01-30/600829_20180130_7.pdf
902,2018-02-01,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-02-01/600829_20180201_1.pdf
903,2018-02-07,人民同泰简式权益变动报告书,/disclosure/listedinfo/announcement/c/2018-02-07/600829_20180207_1.pdf
904,2018-02-07,人民同泰关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2018-02-07/600829_20180207_2.pdf
905,2018-02-08,人民同泰重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2018-02-08/600829_20180208_1.pdf
906,2018-02-15,人民同泰终止重大资产重组的公告,/disclosure/listedinfo/announcement/c/2018-02-15/600829_20180215_1.pdf
907,2018-02-15,人民同泰关于终止重大资产重组事项召开投资者说明会预告的公告,/disclosure/listedinfo/announcement/c/2018-02-15/600829_20180215_2.pdf
908,2018-02-15,人民同泰关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2018-02-15/600829_20180215_3.pdf
